Seventy-eight studies reported the association between rs1800795 and cancer risk, twenty-one studies reported the association between rs1800796 and cancer risk, seventeen studies reported the association between rs1800797 and cancer risk, and twelve studies reported the association between IL-6 promoter polymorphisms and cancer prognosis. This evidence concerns the gene IL6 and cancer.